Form 8-K - Current report:
SEC Accession No. 0000939767-22-000029
Filing Date
2022-02-23
Accepted
2022-02-23 17:23:47
Documents
13
Period of Report
2022-02-23
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K exel-20220223.htm   iXBRL 8-K 31990
5 exel-20220223_g1.jpg GRAPHIC 116418
  Complete submission text file 0000939767-22-000029.txt   424691

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT exel-20220223.xsd EX-101.SCH 1915
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT exel-20220223_lab.xml EX-101.LAB 24137
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT exel-20220223_pre.xml EX-101.PRE 12520
7 EXTRACTED XBRL INSTANCE DOCUMENT exel-20220223_htm.xml XML 10688
Mailing Address 1851 HARBOR BAY PARKWAY ALAMEDA CA 94502
Business Address 1851 HARBOR BAY PARKWAY ALAMEDA CA 94502 6508377000
EXELIXIS, INC. (Filer) CIK: 0000939767 (see all company filings)

EIN.: 043257395 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-30235 | Film No.: 22665113
SIC: 2836 Biological Products, (No Diagnostic Substances)